Diagnostics firm Chronix busts out of stealth, looks for cash
Chronix Biomedical, a diagnostic test development company that has operated mostly in secret since its 2000 inception, has finally come out of its shell — publishing information on its product in three academic journals and announcing its push for commercialization. To fuel the latter, it… Continue Reading
The termite’s blessing: ZeaChem finds more support
Poor termites. They’ll have no part in the ZeaChem facilities that may someday pump out millions of gallons of cellulosic ethanol, even though it’s the humble bug’s legacy that allowed it all to happen. Lakewood, Colo.-based ZeaChem has raised $34 million more for its process,… Continue Reading
Stealth startup Chronix Biomedical raises $2.27M
San Jose, Calif.-based Chronix is working on means to detect and monitor chronic diseases. It has raised a small $2.27 million second round from Pentagram Partners LP, PrairieGold Venture Partners and individual investors, VentureWire reports.
Life sciences briefing: Friday, Oct. 12, 2007
Featured companies: CeraPedics, Lab21, Incisive Surgical, Orasi Medical, Transoma Medcal, ZyGem
(UPDATED: Expanded items on Transoma, Lab21 and Orasi.)
Medical-device maker Transoma files for $75M IPO — St. Paul, Minn.-based Transoma Medical, a developer of implantable wireless diagnostic sensors, filed to raise $75 million in an initial offering. The… Continue Reading